메뉴 건너뛰기




Volumn 109, Issue 3, 2015, Pages 416-426

Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease

Author keywords

Chronic obstructive pulmonary disease; MK 4305; Orexin; Randomized trial; Respiration; Suvorexant

Indexed keywords

PLACEBO; SUVOREXANT; AZEPINE DERIVATIVE; HYPNOTIC AGENT; OREXIN RECEPTOR ANTAGONIST; TRIAZOLE DERIVATIVE;

EID: 84933180862     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.12.010     Document Type: Article
Times cited : (41)

References (47)
  • 2
    • 0028158384 scopus 로고
    • The relation of sleep complaints to respiratory symptoms in a general population
    • Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest 1994; 105:151-4.
    • (1994) Chest , vol.105 , pp. 151-154
    • Klink, M.E.1    Dodge, R.2    Quan, S.F.3
  • 3
    • 0041851055 scopus 로고    scopus 로고
    • Sleep disorders in the elderly with and without chronic airflow obstruction: The SARA study
    • Bellia V, Catalano F, Scichilone N, et al. Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep 2003;26:318-23.
    • (2003) Sleep , vol.26 , pp. 318-323
    • Bellia, V.1    Catalano, F.2    Scichilone, N.3
  • 4
    • 1642447022 scopus 로고    scopus 로고
    • Sleep and chronic obstructive pulmonary disease
    • Kutty K. Sleep and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2004;10:104-12.
    • (2004) Curr Opin Pulm Med , vol.10 , pp. 104-112
    • Kutty, K.1
  • 6
    • 0025248564 scopus 로고
    • Benzodiazepines, breathing, and sleep
    • Guilleminault C. Benzodiazepines, breathing, and sleep. Am J Med 1990;88:25S-8S.
    • (1990) Am J Med , vol.88 , pp. 25S-8S
    • Guilleminault, C.1
  • 7
    • 0028840702 scopus 로고
    • Benzodiazepine side effects: Role of pharmacokinetics and pharmacodynamics
    • Vgontzas AN, Kales A, Bixler EO. Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics. Pharmacology 1995;51:205-23.
    • (1995) Pharmacology , vol.51 , pp. 205-223
    • Vgontzas, A.N.1    Kales, A.2    Bixler, E.O.3
  • 8
    • 0034143762 scopus 로고    scopus 로고
    • Perspectives on the management of insomnia in patients with chronic respiratory disorders
    • George CF. Perspectives on the management of insomnia in patients with chronic respiratory disorders. Sleep 2000;23(Suppl. 1):S31-5.
    • (2000) Sleep , vol.23 , pp. S31-S35
    • George, C.F.1
  • 9
    • 0037287534 scopus 로고    scopus 로고
    • Management of insomnia in patients with chronic obstructive pulmonary disease
    • George CF, Bayliff CD. Management of insomnia in patients with chronic obstructive pulmonary disease. Drugs 2003;63:379-87.
    • (2003) Drugs , vol.63 , pp. 379-387
    • George, C.F.1    Bayliff, C.D.2
  • 10
    • 0034255401 scopus 로고    scopus 로고
    • The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders
    • Kilduff TS, Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 2000;23:359-65.
    • (2000) Trends Neurosci , vol.23 , pp. 359-365
    • Kilduff, T.S.1    Peyron, C.2
  • 11
    • 33846979755 scopus 로고    scopus 로고
    • Promotion of sleep by targeting the orexin system in rats, dogs and humans
    • Brisbare-Roch C, Dingemanse J, Koberstein R, et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007;13:150-5.
    • (2007) Nat Med , vol.13 , pp. 150-155
    • Brisbare-Roch, C.1    Dingemanse, J.2    Koberstein, R.3
  • 12
    • 33847121297 scopus 로고    scopus 로고
    • The neural circuit of orexin (hypocretin): Maintaining sleep and wakefulness
    • Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007;8:171-81.
    • (2007) Nat Rev Neurosci , vol.8 , pp. 171-181
    • Sakurai, T.1
  • 13
    • 24944446762 scopus 로고    scopus 로고
    • Hypocretins (orexins) and sleepwake disorders
    • Baumann CR, Bassetti CL. Hypocretins (orexins) and sleepwake disorders. Lancet Neurol 2005;4:673-82.
    • (2005) Lancet Neurol , vol.4 , pp. 673-682
    • Baumann, C.R.1    Bassetti, C.L.2
  • 14
    • 79951994324 scopus 로고    scopus 로고
    • Orexin receptors: Pharmacology and therapeutic opportunities
    • Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011; 51:243-66.
    • (2011) Annu Rev Pharmacol Toxicol , vol.51 , pp. 243-266
    • Scammell, T.E.1    Winrow, C.J.2
  • 15
    • 84876932335 scopus 로고    scopus 로고
    • Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders: Rationale for development and current status
    • Mieda M, Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current status. CNS Drugs 2013;27:83-90.
    • (2013) CNS Drugs , vol.27 , pp. 83-90
    • Mieda, M.1    Sakurai, T.2
  • 16
    • 0032402181 scopus 로고    scopus 로고
    • Neurons containing hypocretin (orexin) project to multiple neuronal systems
    • Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
    • (1998) J Neurosci , vol.18 , pp. 9996-10015
    • Peyron, C.1    Tighe, D.K.2    Van Den Pol, A.N.3
  • 17
    • 15444371173 scopus 로고    scopus 로고
    • Orexin stimulates breathing via medullary and spinal pathways
    • Young JK, Wu M, Manaye KF, et al. Orexin stimulates breathing via medullary and spinal pathways. J Appl Phys 2005;98:1387-95.
    • (2005) J Appl Phys , vol.98 , pp. 1387-1395
    • Young, J.K.1    Wu, M.2    Manaye, K.F.3
  • 18
    • 53849114680 scopus 로고    scopus 로고
    • Orexinergic modulation of breathing across vigilance states
    • Kuwaki T. Orexinergic modulation of breathing across vigilance states. Respir Physiol Neurobiol 2008;164:204-12.
    • (2008) Respir Physiol Neurobiol , vol.164 , pp. 204-212
    • Kuwaki, T.1
  • 19
    • 53849145356 scopus 로고    scopus 로고
    • Hypothalamic orexins/hypocretins as regulators of breathing
    • Williams RH, Burdakov D. Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med 2008;10:e28.
    • (2008) Expert Rev Mol Med , vol.10 , pp. e28
    • Williams, R.H.1    Burdakov, D.2
  • 20
    • 84863883078 scopus 로고    scopus 로고
    • Respiration and autonomic regulation and orexin
    • Nattie E, Li A. Respiration and autonomic regulation and orexin. Prog Brain Res 2012;198:25-46.
    • (2012) Prog Brain Res , vol.198 , pp. 25-46
    • Nattie, E.1    Li, A.2
  • 21
    • 77954731181 scopus 로고    scopus 로고
    • Discovery of the dual orexin receptor antagonist[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia
    • Cox CD, Breslin MJ, Whitman DB, et al. Discovery of the dual orexin receptor antagonist[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia. J Med Chem 2010;53:5320-32.
    • (2010) J Med Chem , vol.53 , pp. 5320-5332
    • Cox, C.D.1    Breslin, M.J.2    Whitman, D.B.3
  • 22
    • 79956003278 scopus 로고    scopus 로고
    • Promotion of sleep by MK-4305 - A novel dual orexin receptor antagonist
    • Winrow CJ, Gotter AL, Cox CD, et al. Promotion of sleep by MK-4305-a novel dual orexin receptor antagonist. J Neurogenet 2011;25:52-61.
    • (2011) J Neurogenet , vol.25 , pp. 52-61
    • Winrow, C.J.1    Gotter, A.L.2    Cox, C.D.3
  • 23
    • 84871323368 scopus 로고    scopus 로고
    • Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
    • Herring WJ, Snyder E, Budd K, et al. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 2012;79:2265-74.
    • (2012) Neurology , vol.79 , pp. 2265-2274
    • Herring, W.J.1    Snyder, E.2    Budd, K.3
  • 24
    • 84951567173 scopus 로고    scopus 로고
    • Suvorexant in patients with insomnia: Results from two 3-month randomized controlled clinical trials
    • Oct 23 [Epub ahead of print]
    • Herring WJ, Connor KM, Ivgy-May N, et al. Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials. Biol Psychiatry 2014 Oct 23 [Epub ahead of print].
    • (2014) Biol Psychiatry
    • Herring, W.J.1    Connor, K.M.2    Ivgy-May, N.3
  • 25
    • 84898546938 scopus 로고    scopus 로고
    • Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: A phase 3 randomised, double-blind, placebo-controlled trial
    • Michelson D, Snyder E, Paradis E, et al. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol 2014;13:461-71.
    • (2014) Lancet Neurol , vol.13 , pp. 461-471
    • Michelson, D.1    Snyder, E.2    Paradis, E.3
  • 26
    • 84873388862 scopus 로고    scopus 로고
    • Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men
    • Sun H, Kennedy WP, Wilbraham D, et al. Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep 2013;36:259-67.
    • (2013) Sleep , vol.36 , pp. 259-267
    • Sun, H.1    Kennedy, W.P.2    Wilbraham, D.3
  • 30
    • 0344814079 scopus 로고
    • L'examen clinique en psychologie
    • Paris, France: Presses Universitaires de France, Paris
    • Rey A. L'examen clinique en psychologie [Clinical tests in psychology]. Paris, France: Presses Universitaires de France, Paris; 1964.
    • (1964) Clinical Tests in Psychology
    • Rey, A.1
  • 31
    • 0141687342 scopus 로고
    • New York, NY: The Psychological Corporation
    • Wechsler D. WAIS-R manual. New York, NY: The Psychological Corporation; 1981.
    • (1981) WAIS-R Manual
    • Wechsler, D.1
  • 32
    • 84987469571 scopus 로고
    • The use of analogue scales in rating subjective feelings
    • Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Psychol 1974;47:211-8.
    • (1974) Br J Psychol , vol.47 , pp. 211-218
    • Bond, A.1    Lader, M.2
  • 33
    • 33645846956 scopus 로고    scopus 로고
    • Assessment of the AccuSwayPLUS system in measuring the effect of lorazepam on body sway in healthy volunteers
    • Norris V, Baisley K, Calder N, van Troostenburg A-R, Warrington S. Assessment of the AccuSwayPLUS system in measuring the effect of lorazepam on body sway in healthy volunteers. Int J Pharm Med 2005;19:233-8.
    • (2005) Int J Pharm Med , vol.19 , pp. 233-238
    • Norris, V.1    Baisley, K.2    Calder, N.3    Van Troostenburg, A.-R.4    Warrington, S.5
  • 34
    • 41549130564 scopus 로고    scopus 로고
    • Effect of ramelteon, a selective MT1/MT2-receptor agonist, on respiration during sleep in mild to moderate COPD
    • Kryger M, Wang-Weigand S, Zhang J, Roth T. Effect of ramelteon, a selective MT1/MT2-receptor agonist, on respiration during sleep in mild to moderate COPD. Sleep Breath 2008;12:243-50.
    • (2008) Sleep Breath , vol.12 , pp. 243-250
    • Kryger, M.1    Wang-Weigand, S.2    Zhang, J.3    Roth, T.4
  • 35
    • 77956599468 scopus 로고    scopus 로고
    • Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1∗0602 status
    • Han F, Mignot E, Wei YC, et al. Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1∗0602 status. Eur Respir J 2010;36:577-83.
    • (2010) Eur Respir J , vol.36 , pp. 577-583
    • Han, F.1    Mignot, E.2    Wei, Y.C.3
  • 36
    • 0027222674 scopus 로고
    • Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease
    • Steens RD, Pouliot Z, Millar TW, Kryger MH, George CF. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 1993;16:318-26.
    • (1993) Sleep , vol.16 , pp. 318-326
    • Steens, R.D.1    Pouliot, Z.2    Millar, T.W.3    Kryger, M.H.4    George, C.F.5
  • 37
    • 77349122544 scopus 로고    scopus 로고
    • Temazepam 10 mg does not affect breathing and gas exchange in patients with severe normocapnic COPD
    • Stege G, Heijdra YF, van den Elshout FJ, et al. Temazepam 10 mg does not affect breathing and gas exchange in patients with severe normocapnic COPD. Respir Med 2010;104:518-24.
    • (2010) Respir Med , vol.104 , pp. 518-524
    • Stege, G.1    Heijdra, Y.F.2    Van Den Elshout, F.J.3
  • 38
    • 39049113780 scopus 로고    scopus 로고
    • Overlap syndrome: Obstructive sleep apnea in patients with chronic obstructive pulmonary disease
    • Weitzenblum E, Chaouat A, Kessler R, Canuet M. Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:237-41.
    • (2008) Proc Am Thorac Soc , vol.5 , pp. 237-241
    • Weitzenblum, E.1    Chaouat, A.2    Kessler, R.3    Canuet, M.4
  • 39
    • 0034636477 scopus 로고    scopus 로고
    • Prospective study of the association between sleep-disordered breathing and hypertension
    • Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
    • (2000) N Engl J Med , vol.342 , pp. 1378-1384
    • Peppard, P.E.1    Young, T.2    Palta, M.3    Skatrud, J.4
  • 40
    • 4544347749 scopus 로고    scopus 로고
    • Sleep-disordered breathing, glucose intolerance, and insulin resistance: The sleep heart health study
    • Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study. Am J Epidemiol 2004;160:521-30.
    • (2004) Am J Epidemiol , vol.160 , pp. 521-530
    • Punjabi, N.M.1    Shahar, E.2    Redline, S.3    Gottlieb, D.J.4    Givelber, R.5    Resnick, H.E.6
  • 41
    • 0027403440 scopus 로고
    • One negative polysomnogram does not exclude obstructive sleep apnea
    • Meyer TJ, Eveloff SE, Kline LR, Millman RP. One negative polysomnogram does not exclude obstructive sleep apnea. Chest 1993;103:756-60.
    • (1993) Chest , vol.103 , pp. 756-760
    • Meyer, T.J.1    Eveloff, S.E.2    Kline, L.R.3    Millman, R.P.4
  • 42
    • 67649669068 scopus 로고    scopus 로고
    • Clinical diagnosis of sleep apnea based on single night of polysomnography vs. two nights of polysomnography
    • Ahmadi N, Shapiro GK, Chung SA, Shapiro CM. Clinical diagnosis of sleep apnea based on single night of polysomnography vs. two nights of polysomnography. Sleep Breath 2009;13:221-6.
    • (2009) Sleep Breath , vol.13 , pp. 221-226
    • Ahmadi, N.1    Shapiro, G.K.2    Chung, S.A.3    Shapiro, C.M.4
  • 43
    • 64149098535 scopus 로고    scopus 로고
    • Assessment of the test-retest reliability of laboratory polysomnography
    • Levendowski DJ, Zack N, Rao S, et al. Assessment of the test-retest reliability of laboratory polysomnography. Sleep Breath 2009;13:163-7.
    • (2009) Sleep Breath , vol.13 , pp. 163-167
    • Levendowski, D.J.1    Zack, N.2    Rao, S.3
  • 44
    • 35648987905 scopus 로고    scopus 로고
    • Contribution of orexin in hypercapnic chemoreflex: Evidence from genetic and pharmacological disruption and supplementation studies in mice
    • Deng BS, Nakamura A, Zhang W, Yanagisawa M, Fukuda Y, Kuwaki T. Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice. J Appl Phys 2007;103:1772-9.
    • (2007) J Appl Phys , vol.103 , pp. 1772-1779
    • Deng, B.S.1    Nakamura, A.2    Zhang, W.3    Yanagisawa, M.4    Fukuda, Y.5    Kuwaki, T.6
  • 45
    • 79251504455 scopus 로고    scopus 로고
    • Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle
    • Li A, Nattie E. Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle. J Physiol 2010;588:2935-44.
    • (2010) J Physiol , vol.588 , pp. 2935-2944
    • Li, A.1    Nattie, E.2
  • 47
    • 58149354822 scopus 로고    scopus 로고
    • Hypnotic use for insomnia management in chronic obstructive pulmonary disease
    • Roth T. Hypnotic use for insomnia management in chronic obstructive pulmonary disease. Sleep Med 2009;10:19-25.
    • (2009) Sleep Med , vol.10 , pp. 19-25
    • Roth, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.